BMJ Best Practice

参考文献

关键文献

Gahlinger PM. Club drugs: MDMA, gamma-hydroxybutyrate (GHB), rohypnol, and ketamine. Am Fam Physician. 2004;69:2619-2627.

Spivey WH. Flumazenil and seizures: analysis of 43 cases. Clin Ther. 1992;14:292-305.

参考文章

1.  Hojer J, Baehrendtz S. The effect of flumazenil (Ro 15-1788) in the management of self-induced benzodiazepine poisoning. A double-blind controlled study. Acta Med Scand. 1988;224:357-365.

2.  Gahlinger PM. Club drugs: MDMA, gamma-hydroxybutyrate (GHB), rohypnol, and ketamine. Am Fam Physician. 2004;69:2619-2627.

3.  Lechevallier-Michel N, Berr C, Fourrier-Reglat A. Incidence and characteristics of benzodiazepine use in an elderly cohort: the EVA study. Therapie. 2005;60:561-566.

4.  Gleason PP, Schulz R, Smith NL, et al. Correlates and prevalence of benzodiazepine use in community-dwelling elderly. J Gen Intern Med. 1998;13:243-250.

5.  Valenstein M, Khanujua Taylor K, Austin K, et al. Benzodiazepine use among depressed patients treated in mental health settings. Am J Psychiatry. 2004;161:654-661.

6.  Guina J, Rossetter SR, DeRhodes BJ, et al. Benzodiazepines for PTSD: a systematic review and meta-analysis. J Psychiatr Pract. 2015;21:281-303.

7.  Brunoni AR, Nunes MA, Figueiredo R, et al. Patterns of benzodiazepine and antidepressant use among middle-aged adults: the Brazilian longitudinal study of adult health (ELSA-Brasil). J Affect Disord. 2013;151:71-77.

8.  Préville M, Vasiliadis HM, Bossé C, et al. Pattern of psychotropic drug use among older adults having a depression or an anxiety disorder: results from the longitudinal ESA study. Can J Psychiatry. 2011;56:348-357.

9.  Saarelainen L, Tolppanen AM, Koponen M, et al. Risk of hip fracture in benzodiazepine users with and without Alzheimer disease. J Am Med Dir Assoc. 2017;18:87;e15-e87;e21.

10.  Taipale H, Koponen M, Tanskanen A, et al. Use of benzodiazepines and related drugs is associated with a risk of stroke among persons with Alzheimer's disease. Int Clin Psychopharmacol. 2017;32:135-141.

11.  Huang WS, Muo CH, Chang SN, et al. Benzodiazepine use and risk of stroke: a retrospective population-based cohort study. Psychiatry Clin Neurosci. 2014;68:255-262.

12.  Buckley NA, Dawson AH, Whyte IM, et al. Relative toxicity of benzodiazepines in overdose. BMJ. 1995;310:219-221.

13.  Warner M, Trinidad JP, Bastian BA, et al. Drugs most frequently involved in drug overdose deaths: United States, 2010-2014. Natl Vital Stat Rep. 2016;65:1-15.

14.  Bachhuber MA, Hennessy S, Cunningham CO, et al. Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996-2013. Am J Public Health. 2016;106:686-688.

15.  Hawton K, Bergen H, Casey D, et al. Self-harm in England: a tale of three cities. Multicentre study of self-harm. Soc Psychiatry Psychiatr Epidemiol. 2007;42:513-521.

16.  Ticehurst S, Carter GL, Clover KA, et al. Elderly patients with deliberate self-poisoning treated in an Australian general hospital. Int Psychogeriatr. 2002;14:97-105.

17.  Okamoto R, Itoh Y, Murata Y, et al. Reduction of group II metabotropic glutamate receptors during development of benzodiazepine dependence. Pharmacology. 2013;91:145-152.

18.  Backmund M, Meyer K, Henkel C, et al. Co-consumption of benzodiazepines in heroin users, methadone-substituted and codeine-substituted patients. J Addict Dis. 2005;24:17-29.

19.  Man LH, Best D, Gossop M, et al. Relationship between prescribing and risk of opiate overdose among drug users in and out of maintenance treatment. Eur Addict Res. 2004;10:35-40.

20.  Gahlinger PM. Illegal drugs: A complete guide to their history, chemistry, use and abuse. New York: Penguin (Plume); 2004.

21.  Olfson M, King M, Schoenbaum M. Benzodiazepine use in the United States. JAMA Psychiatry. 2015;72:136-142.

22.  Lugoboni F, Mirijello A, Faccini M, et al. Quality of life in a cohort of high-dose benzodiazepine dependent patients. Drug Alcohol Depend. 2014;142:105-109.

23.  Harnod T, Lin CL, Sung FC, et al. An association between benzodiazepine use and occurrence of benign brain tumors. J Neurol Sci. 2014;336:8-12.

24.  Vozoris NT, Fischer HD, Wang X, et al. Benzodiazepine use among older adults with chronic obstructive pulmonary disease: a population-based cohort study. Drugs Aging. 2013;30:183-192.

25.  Billioti de Gage S, Moride Y, Ducruet T, et al. Benzodiazepine use and risk of Alzheimer's disease: case-control study. BMJ. 2014;349:g5205.

26.  Konopka A, Pełka-Wysiecka J, Grzywacz A, et al. Psychosocial characteristics of benzodiazepine addicts compared to not addicted benzodiazepine users. Prog Neuropsychopharmacol Biol Psychiatry. 2013;40:229-235.

27.  Willems IA, Gorgels WJ, Oude Voshaar RC, et al. Tolerance to benzodiazepines among long-term users in primary care. Fam Pract. 2013;30:404-410.

28.  McCabe SE, West BT. Medical and nonmedical use of prescription benzodiazepine anxiolytics among US high school seniors. Addict Behav. 2014;39:959-964.

29.  Janhsen K, Roser P, Hoffmann K. The problems of long-term treatment with benzodiazepines and related substances. Dtsch Arztebl Int. 2015;112:1-7.

30.  Wu AH, McKay C, Broussard LA, et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department. Clin Chem. 2003;49:357-379.

31.  Haverkos GP, DiSalvo RP, Imhoff TE. Fatal seizures after flumazenil administration in a patient with mixed overdose. Ann Pharmacother. 1994;28:1347-1349.

32.  Spivey WH. Flumazenil and seizures: analysis of 43 cases. Clin Ther. 1992;14:292-305.

33.  Velluti R, Pedemonte M. Differential effects of benzodiazepines on cochlear and auditory nerve responses. Electroencephalogr Clin Neurophysiol. 1986;64:556-562.

34.  Bezchlibnyk-Butler JZ, Jeffries JJ. Clinical handbook of psychotropic drugs, 16th ed. Toronto, Canada: Hogrefe & Huber Publishing; 2006.

35.  Ngo AS, Anthony CR, Samuel M, et al. Should a benzodiazepine antagonist be used in unconscious patients presenting to the emergency department? Resuscitation. 2007;74:27-37.

36.  Kyong YY, Park JT, Choi KH. Serial monitoring of sedation scores in benzodiazepine overdose. Am J Emerg Med. 2014;32:1438;e5-e6.

37.  Vale JA, Kulig K; American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. Position paper: gastric lavage. J Toxicol Clin Toxicol. 2004;42:933-943.

38.  Chyka PA, Seger D. Position statement: single-dose activated charcoal. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol. 1997;35:721-741.

39.  Darker CD, Sweeney BP, Barry JM, et al. Psychosocial interventions for benzodiazepine harmful use, abuse or dependence. Cochrane Database Syst Rev. 2015;(5):CD009652.

使用此内容应接受我们的免责声明